دورية أكاديمية

343: INITIAL LOW-MOLECULAR-WEIGHT HEPARIN USE AFTER IMPLEMENTATION OF A PULMONARY EMBOLISM RESPONSE TEAM.

التفاصيل البيبلوغرافية
العنوان: 343: INITIAL LOW-MOLECULAR-WEIGHT HEPARIN USE AFTER IMPLEMENTATION OF A PULMONARY EMBOLISM RESPONSE TEAM.
المؤلفون: Betthauser, Kevin1 (AUTHOR), Sanfilippo, Kristen2 (AUTHOR), Atuiri, Clifford3 (AUTHOR), Beasley, Melissa4 (AUTHOR), Kramer, Kimberly5 (AUTHOR), Samant, Maanasi2 (AUTHOR)
المصدر: Critical Care Medicine. 2023 Supplement, Vol. 51, p157-157. 1p.
مصطلحات موضوعية: *LOW-molecular-weight heparin, *PULMONARY embolism
مستخلص: B Conclusions: b Our institution has observed increased utilization of LMWH as an initial anticoagulant in patients with low or intermediate risk PE for whom PERT is activated. The implementation of a multidisciplinary pulmonary embolism response team (PERT) has been associated with improved patient outcomes and changes in anticoagulant utilization. B Introduction: b Consensus guidelines recommend low molecular weight heparin (LMWH) over unfractionated heparin (UFH) in most PE patients, however, UFH remains the most common initial anticoagulant at many institutions. [Extracted from the article]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:00903493
DOI:10.1097/01.ccm.0000907100.18180.64